The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: Results of a comparative study

1999-01-28

Additional Metadata
Keywords	Docetaxel, Fluid retention, Hydroxyethylrutosiden
Persistent URL	doi.org/10.1007/s002800050880, hdl.handle.net/1765/60780
Journal	Cancer Chemotherapy and Pharmacology
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Pronk, L., van Putten, W., van Beurden, V., de Boer-Dennert, M., Stoter, G., & Verweij, J. (1999). The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: Results of a comparative study. Cancer Chemotherapy and Pharmacology, 43(2), 173–177. doi:10.1007/s002800050880

Publication